Closing the Gap: A Private Push for Faster Autism Diagnosis in Florida

CORAL GABLES, FL – June 29, 2026 – For countless American families, the journey to understanding a child’s developmental challenges is stalled in a painful limbo—a waiting list. This period, often stretching from six months to over a year, represents a critical window of lost time for children who may have autism spectrum disorder (ASD). In a direct response to this systemic bottleneck, Acorn Health, a national provider of Applied Behavior Analysis (ABA) therapy, announced today the expansion of its diagnostic services in Florida, opening new evaluation centers in Tampa and Orlando.

While on its face this is a story of corporate expansion, it is more profoundly a story about the systems of care we are building. It reveals a landscape where private enterprise is stepping in to fill voids in public health infrastructure, driven by both a pressing community need and significant market opportunity. The new centers, staffed by licensed psychologists, promise to deliver comprehensive evaluations for children as young as 18 months, aiming to shorten the agonizing wait for answers that parents and pediatricians agree has reached a crisis point.

The Agonizing Wait: A System Under Strain

The claim of “waiting too long,” as stated by Acorn Health’s Chief Clinical Officer Krista Orellana, is a stark understatement. Across the country, the demand for autism assessments has dramatically outpaced the supply of qualified diagnosticians. National data from early 2026 reveals that the average wait for an evaluation is between 6 and 12 months, with some regions reporting waits of 18 months or more. In Florida, the situation is similarly dire, with families reporting waits of 8 to 24 months for both diagnosis and the initiation of therapy.

This delay has profound consequences. The average age of autism diagnosis in the U.S. hovers stubbornly around four years old, despite the fact that reliable screening can occur at 18 months. “We know that the brain is most malleable in the first few years of life,” notes one developmental pediatrician not affiliated with Acorn Health. “When a child waits a year or more for a diagnosis, they miss out on a year of intervention that can have a significant impact on their long-term developmental trajectory.”

This delay doesn't just affect the child; it places immense strain on the entire family. Parents navigate uncertainty, stress, and the challenge of managing a child’s needs without a clear roadmap or access to support services. The relief that a diagnosis can bring is often just the first step, followed by another wait to begin therapies like ABA, which are the standard of care for autism. Acorn’s move to bring diagnostic capabilities in-house is a clear strategy to collapse this timeline.

A Strategic Response in a Growing Market

While the benefit to families is clear, Acorn Health's expansion is also a shrewd business decision within one of healthcare’s most rapidly expanding sectors. The U.S. market for ABA therapy was estimated at nearly $8 billion in 2025 and is projected to climb toward $10 billion by 2030, fueled by rising autism prevalence—now estimated by the CDC at 1 in 31 children—and broader insurance coverage.

This growth has attracted significant attention from private equity firms and investors, who see a fragmented market ripe for consolidation and a durable, non-discretionary demand for services. By adding diagnostic services, a company like Acorn Health, which operates over 70 therapy centers, creates an integrated service line. It can shepherd a family from the first point of concern, through diagnosis, and directly into its primary revenue-generating service: ABA therapy. This vertical integration not only provides a better, more streamlined experience for the consumer but also creates a reliable pipeline of clients for the company.

In the Tampa and Orlando markets, Acorn Health is not without competition. Providers ranging from major hospital systems like AdventHealth to specialized clinics like Hopebridge Autism Therapy Centers already offer diagnostic services. However, the sheer scale of the demand means the market is far from saturated. The existence of long waitlists at these established centers is precisely the opportunity Acorn is targeting. By hiring experienced psychologists like Dr. Amanda Zanko-Knight in Tampa and Dr. Gregory Worthington in Orlando, the company is signaling a commitment to high-quality, evidence-based assessments that can stand as a reliable gateway to care.

The Clinical Imperative and the Insurance Labyrinth

At the heart of this expansion is a clinical truth: early and accurate diagnosis is the cornerstone of effective treatment. “If a child is showing signs of ASD, comprehensive psychological testing can clarify concerns and support an accurate diagnosis, which is vital to developing effective treatment plans,” said Dr. Worthington in the company’s announcement. This process involves using “gold-standard” assessment tools and clinical interviews to understand a child’s unique profile of strengths and challenges in social communication, sensory processing, and behavior.

An accurate diagnosis is the key that unlocks everything else. It is the prerequisite for insurance coverage, school-based support services, and specialized therapies. By providing this key, Acorn Health positions itself as an essential partner to families at the most critical juncture of their journey.

However, access is a two-part equation: availability and affordability. The press release states that “most major commercial insurance plans are accepted.” For families, this simple phrase masks a complex reality. While Florida law mandates coverage for autism services for many types of plans, navigating the specifics of deductibles, co-pays, in-network versus out-of-network providers, and pre-authorization requirements remains a daunting task. Federal parity laws have helped eliminate arbitrary caps on coverage, but the administrative burden on families remains high.

The success of this expansion, and others like it, will hinge not only on the quality of the clinical services but also on the ability to help families navigate this financial labyrinth effectively. The true measure of closing the access gap is ensuring that a diagnosis is not just faster, but also financially attainable for the average family.

Acorn Health’s expansion into diagnostics in Florida and soon Tennessee is a powerful example of how corporate strategy is increasingly intersecting with fundamental community needs. It offers a tangible solution for families caught in an overburdened system, while simultaneously cementing the company’s position in a lucrative market. This model, where private capital flows to fill the service gaps in our social safety nets, is becoming a defining feature of modern American healthcare, reshaping the landscape of care one clinic at a time.